Welcome Logout
Skip to main content
NOFSI Logo

National Social Inclusion Office

  • Home
  • About
    • Our Team
    • Research and Reports
    • Training
    • Parliamentary Questions
      • PQ's 2023
      • PQ's 2022
      • PQ's 2021
      • PQ's 2020
      • PQ's 2019
      • PQ's 2018
      • PQ's 2017
      • PQ's 2016
    • Translation Hub
      • Mobile Health Apps
      • Multilingual resources and Translated material
      • Translation & Interpreting Company
    • Latest News
  • Homeless
    • Resources and Reports
    • Contact
    • Our Plan
    • COVID-19
    • Projects
    • Homeless Data
  • Addiction
    • Policy, Strategy and Frameworks
    • COVID-19
    • Clinical Matters
      • Suboxone
      • Naloxone
      • Opioid Substitute Treatment (OST)
      • Pharmacy Needle Exchange
    • Supervised Injecting Facilities
      • FAQs
    • National Addiction Training
      • Alcohol and Substance Use (SAOR)
      • National Hidden Harm Project
    • DRUGS.ie
  • Intercultural Health
    • COVID-19
    • Protection Applicants
    • Irish Refugee Resettlement Programme
    • Mobile Health Screening Unit
    • Ethnic Equality Monitoring
    • Translation Hub
    • Projects
  • Travellers and Roma
    • Irish Travellers
      • The National Traveller Mental Health Service
      • COVID-19
      • Traveller Projects and Resources
    • Roma Community
      • COVID-19
      • Roma Health Advocacy Projects
  • Domestic Violence
    • Human Trafficking
    • Other Work
    • COVID-19
    • Female Genital Mutilation (FGM)
  • LGBTI
  • Homeless
  • Addiction
  • Intercultural Health
  • Travellers and Roma
  • Domestic Violence
  • LGBTI
  1. National Social Inclusion Office
  2. Addiction
  3. Clinical Matters
  4. Suboxone

Suboxone

Suboxone Resources

Clinical Opiate Withdrawal Scale (COWS).pdf (size 35.7 KB)

Objective Opioid Withdrawal Scale (OOWS).pdf (size 28.3 KB)

Statutory Instrument No 522 of 201.pdf (size 51.6 KB)

Summary of Product Characteristics.pdf (size 543.6 KB)

Buprenorphine Naloxone Suboxone Training 2018.pptx (size 1.4 MB)

 
  • About
  • Homeless
  • Addiction
    • Policy, Strategy and Frameworks
    • COVID-19
    • Clinical Matters
      • Suboxone
      • Naloxone
      • Opioid Substitute Treatment (OST)
      • Pharmacy Needle Exchange
    • Supervised Injecting Facilities
    • National Addiction Training
    • DRUGS.ie
  • Intercultural Health
  • Travellers and Roma
  • Domestic Violence
  • LGBTI

For information about the National Social Inclusion Office call: 01 778 5168, or Email: socialinclusion@hse.ie.

  • Services
    • All Health Services
    • Latest News
    • My health my language
    • COVID-19 resources and translations
    • Publications and Reports
    • Patients awaiting admission (TrolleyGAR)
    • You and Your Health Service
    • Order HSE resources
    • Healthcare in Ireland
  • Health A to Z
    • Baby and Child Health
    • Immunisation
    • Healthy Ireland
  • Staff and Careers
    • Jobs
    • Online payslips
    • Training
    • Staff resources
    • Workplace Health and Wellbeing Unit
    • Safety and Wellbeing
    • Staff engagement
    • PCRS Online
  • About Us
    • Our Health Service
    • HSE Structure
    • Quality Improvement Division
    • Public Representatives
    • Non Statutory Sector
    • FOI Publication Scheme

Contact Us

HSE National Social Inclusion Office

Address: Mill Lane, Palmerstown, Dublin 20, D20 KH63.

Phone: 01-620 1703

Email: Socialinclusion@hse.ie

 © 2023 Health Service Executive

  • Cookie Settings
  • Cookie Statement
  • Accessibility
  • Privacy Statement
  • Disclaimer